Review




Structured Review

Mabtech Inc elispot plus kits for mouse il-5
Elispot Plus Kits For Mouse Il 5, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+plus+kits+for+mouse+il-5/pmc09718471-327-16-21?v=Mabtech+Inc
Average 90 stars, based on 1 article reviews
elispot plus kits for mouse il-5 - by Bioz Stars, 2026-08
90/100 stars

Images



Similar Products

90
Mabtech Inc elispot plus kits for mouse il-5
Elispot Plus Kits For Mouse Il 5, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+plus+kits+for+mouse+il-5/pmc09718471-327-16-21?v=Mabtech+Inc
Average 90 stars, based on 1 article reviews
elispot plus kits for mouse il-5 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Mabtech Inc mouse il-5 elispot plus kit
Effects of EE caging on primary and secondary vaccine responses and spleen composition. (A) Influenza vaccine–specific IgG titers were measured in serum from mice vaccinated once (prime) or twice (boost) using an ELISA. In primed groups, EE mice had slightly lower IgG titers than control-caged mice (p = 0.0943), whereas in boosted groups, EE mice had slightly higher IgG titers than controls (p = 0.1950), although neither difference was statistically significant. Control mice exhibited an increase in IgG titer, from prime to boost, of 11.4%, whereas EE mice exhibited an increase of 23.8% (control, p = 0.0138; EE, p = 0.0006). (B) 1 × 106 splenocytes were stimulated with either PBS or vaccine for 24 h in an IL-5 <t>ELISPOT</t> assay. Primed animals showed no difference between caging groups, whereas splenocytes from boosted EE mice that were stimulated with vaccine had a significantly greater frequency of IL-5–secreting cells than boosted controls (p = 0.0493). The increase in frequency of IL-5–secreting cells from prime to boost was larger in EE mice (334.2%) than controls (177.9%) (control, p = 0.0230; EE, p = 0.0005). (C) A nonsignificant negative trend was observed between IL-5 production and mean FCM concentration (r2 = 0. 38, p = 0.0781). (D) Spleen mass per unit body mass was found to be significantly lower in boosted control-caged mice than boosted EE-caged mice (p = 0.0001). (E) A negative relationship was observed between mean FCM concentration and spleen mass per unit body mass in vaccine-boosted animals (r2 = 0.90, p < 0.0001). (F, G) Negative relationships were also observed between mean FCM concentration and CD19+ B cell number and CD4−CD8− lymphocyte number (CD19+, r2 = 0.39, p = 0.0533; CD4−CD8−, r2 = 0.52, p = 0.0190). Data are mean ± SEM. *p < 0.05, ***p < 0.001.
Mouse Il 5 Elispot Plus Kit, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+plus+kits+for+mouse+il-5/pmc04002849-113-9-14?v=Mabtech+Inc
Average 90 stars, based on 1 article reviews
mouse il-5 elispot plus kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Effects of EE caging on primary and secondary vaccine responses and spleen composition. (A) Influenza vaccine–specific IgG titers were measured in serum from mice vaccinated once (prime) or twice (boost) using an ELISA. In primed groups, EE mice had slightly lower IgG titers than control-caged mice (p = 0.0943), whereas in boosted groups, EE mice had slightly higher IgG titers than controls (p = 0.1950), although neither difference was statistically significant. Control mice exhibited an increase in IgG titer, from prime to boost, of 11.4%, whereas EE mice exhibited an increase of 23.8% (control, p = 0.0138; EE, p = 0.0006). (B) 1 × 106 splenocytes were stimulated with either PBS or vaccine for 24 h in an IL-5 ELISPOT assay. Primed animals showed no difference between caging groups, whereas splenocytes from boosted EE mice that were stimulated with vaccine had a significantly greater frequency of IL-5–secreting cells than boosted controls (p = 0.0493). The increase in frequency of IL-5–secreting cells from prime to boost was larger in EE mice (334.2%) than controls (177.9%) (control, p = 0.0230; EE, p = 0.0005). (C) A nonsignificant negative trend was observed between IL-5 production and mean FCM concentration (r2 = 0. 38, p = 0.0781). (D) Spleen mass per unit body mass was found to be significantly lower in boosted control-caged mice than boosted EE-caged mice (p = 0.0001). (E) A negative relationship was observed between mean FCM concentration and spleen mass per unit body mass in vaccine-boosted animals (r2 = 0.90, p < 0.0001). (F, G) Negative relationships were also observed between mean FCM concentration and CD19+ B cell number and CD4−CD8− lymphocyte number (CD19+, r2 = 0.39, p = 0.0533; CD4−CD8−, r2 = 0.52, p = 0.0190). Data are mean ± SEM. *p < 0.05, ***p < 0.001.

Journal: Molecular Medicine

Article Title: Environmental Enrichment Alters Splenic Immune Cell Composition and Enhances Secondary Influenza Vaccine Responses in Mice

doi: 10.2119/molmed.2013.00158

Figure Lengend Snippet: Effects of EE caging on primary and secondary vaccine responses and spleen composition. (A) Influenza vaccine–specific IgG titers were measured in serum from mice vaccinated once (prime) or twice (boost) using an ELISA. In primed groups, EE mice had slightly lower IgG titers than control-caged mice (p = 0.0943), whereas in boosted groups, EE mice had slightly higher IgG titers than controls (p = 0.1950), although neither difference was statistically significant. Control mice exhibited an increase in IgG titer, from prime to boost, of 11.4%, whereas EE mice exhibited an increase of 23.8% (control, p = 0.0138; EE, p = 0.0006). (B) 1 × 106 splenocytes were stimulated with either PBS or vaccine for 24 h in an IL-5 ELISPOT assay. Primed animals showed no difference between caging groups, whereas splenocytes from boosted EE mice that were stimulated with vaccine had a significantly greater frequency of IL-5–secreting cells than boosted controls (p = 0.0493). The increase in frequency of IL-5–secreting cells from prime to boost was larger in EE mice (334.2%) than controls (177.9%) (control, p = 0.0230; EE, p = 0.0005). (C) A nonsignificant negative trend was observed between IL-5 production and mean FCM concentration (r2 = 0. 38, p = 0.0781). (D) Spleen mass per unit body mass was found to be significantly lower in boosted control-caged mice than boosted EE-caged mice (p = 0.0001). (E) A negative relationship was observed between mean FCM concentration and spleen mass per unit body mass in vaccine-boosted animals (r2 = 0.90, p < 0.0001). (F, G) Negative relationships were also observed between mean FCM concentration and CD19+ B cell number and CD4−CD8− lymphocyte number (CD19+, r2 = 0.39, p = 0.0533; CD4−CD8−, r2 = 0.52, p = 0.0190). Data are mean ± SEM. *p < 0.05, ***p < 0.001.

Article Snippet: ELISPOT Assay Interleukin (IL)-5 production was measured with a mouse IL-5 ELISPOT plus kit (Mabtech, Cincinnati, OH, USA) according to the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Control, Enzyme-linked Immunospot, Concentration Assay